Drug Profile
Interferon-gamma-1a - Asubio Pharma
Alternative Names: Biogamma; SUN 4800Latest Information Update: 11 Apr 2007
Price :
$50
*
At a glance
- Originator Asubio Pharma
- Class Antineoplastics; Antivirals; Interferons; Lymphokines
- Mechanism of Action Interferon stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Mycosis fungoides
Most Recent Events
- 16 Sep 2005 Daiichi Suntory Pharma has been acquired by Daiichi Pharmaceutical
- 06 Jan 2003 Suntory's pharmaceutical division has been transferred to a new joint venture of Suntory and Daiichi Pharmaceutical, Daiichi Suntory Pharma
- 17 Jul 1992 Launched for Mycosis fungoides in Japan (Injection)